Characteristics of the patients
| MMR competent (n = 688) | MMR deficient (n = 66) | p Value | |
|---|---|---|---|
| p Values were calculated using the χ2 test. | |||
| MMR, mismatch repair; TNM, tumour, node, metastases. | |||
| Age (y) (mean (SD) | 70.0 (11.1) | 68.8 (14.5) | 0.4 |
| Sex (n (%)) | 0.0001 | ||
| Males | 427 (62) | 22 (34) | |
| Females | 261 (38) | 44 (66) | |
| TNM (n (%)) | 0.06 | ||
| Stage I | 99 (14) | 4 (6) | |
| Stage II | 261 (38) | 35 (53) | |
| Stage III | 191 (28) | 18 (27) | |
| Stage IV | 137 (20) | 9 (14) | |
| Follow up (days) (mean) | 610 | 599 | 0.8 |
| Chemotherapy (n (%)) | 330 (48) | 23 (35) | 0.04 |
| Vital status (n (%)) | |||
| Dead | 192 (28) | 14 (21) | 0.3 |
| Recurrence (n (%)) | 113 (20) | 7 (12) | 0.1 |